229 results on '"Campieri M"'
Search Results
2. New insights into the brain involvement in patients with Crohn’s disease: a voxel-based morphometry study
3. Medical treatment and management of severe ulcerative colitis
4. CT-guided percutaneous pelvic abscess drainage in Crohn’s disease
5. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
6. Local Injection of Infliximab for the Treatment of Perianal Crohn’s Disease
7. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
8. The effect of transient intestinal ischemia on inflammatory parameters
9. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
10. Risk of permanent stoma in extensive Crohnʼs colitis: the impact of biological drugs
11. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study
12. Use of anti-tumour necrosis factor agents in inflammatory bowel disease: European guidelines for 2001–2003
13. New steroids and new salicylates in inflammatory bowel disease: A critical appraisal. (Paper)
14. Distinct proteomic profiles characterise non-erosive from erosive reflux disease
15. Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
16. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
17. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX® with Asacol®
18. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
19. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis
20. Oral budesonide in the treatment of chronic refractory pouchitis
21. Review article: aminosalicylates for distal colitis
22. Antibiotic treatment of Crohnʼs disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
23. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients
24. Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches
25. Probiotics and barrier function in colitis
26. Modulation of human dendritic cell phenotype and function by probiotic bacteria
27. problematic proctitis and distal colitis
28. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation
29. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
30. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study
31. Review article: medical treatment of severe ulcerative colitis
32. Treatment of distal colitis
33. Monitoring activity in ulcerative colitis
34. The management of refractory Crohn's disease
35. Treatment of mild to moderate ulcerative colitis and pouchitis
36. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
37. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis
38. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis
39. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
40. MCP-3 in inflammatory bowel disease
41. Ultrasonographic findings in Crohnʼs disease
42. Rifaximin systemic absorption in patients with ulcerative colitis
43. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis
44. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
45. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial
46. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis
47. Oral budesonide as maintenance therapy in Crohn's disease-results of a 12-month study
48. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome
49. Probiotics — Role in inflammatory bowel disease
50. Effect of probiotic strains on interleukin 8 production by HT29/19A cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.